Charles Schwab Investment Management Inc. grew its position in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 0.4% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 388,638 shares of the medical technology company’s stock after purchasing an additional 1,408 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.83% of Teleflex worth $94,062,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. lifted its stake in Teleflex by 2.1% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,633,473 shares of the medical technology company’s stock worth $2,155,174,000 after purchasing an additional 181,393 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Teleflex by 1.7% during the first quarter. Vanguard Group Inc. now owns 5,147,062 shares of the medical technology company’s stock worth $1,826,333,000 after acquiring an additional 83,858 shares during the period. BlackRock Inc. increased its position in shares of Teleflex by 0.3% during the first quarter. BlackRock Inc. now owns 3,982,749 shares of the medical technology company’s stock worth $1,008,870,000 after acquiring an additional 13,204 shares during the period. Wellington Management Group LLP increased its position in shares of Teleflex by 0.3% during the first quarter. Wellington Management Group LLP now owns 3,100,514 shares of the medical technology company’s stock worth $785,391,000 after acquiring an additional 7,795 shares during the period. Finally, Morgan Stanley increased its position in shares of Teleflex by 535.8% during the fourth quarter. Morgan Stanley now owns 2,691,192 shares of the medical technology company’s stock worth $671,803,000 after acquiring an additional 2,267,889 shares during the period. 97.15% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on TFX shares. JMP Securities cut their price objective on Teleflex from $315.00 to $285.00 and set a “market outperform” rating on the stock in a research report on Friday, November 3rd. Royal Bank of Canada upped their price objective on Teleflex from $218.00 to $228.00 and gave the stock an “outperform” rating in a research report on Friday, November 3rd. Raymond James cut their price objective on Teleflex from $272.00 to $255.00 and set an “outperform” rating on the stock in a research report on Monday, August 7th. Truist Financial increased their target price on Teleflex from $210.00 to $221.00 and gave the company a “hold” rating in a report on Monday, November 6th. Finally, StockNews.com assumed coverage on Teleflex in a report on Thursday, October 5th. They issued a “hold” rating on the stock. Six research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, Teleflex presently has an average rating of “Hold” and an average price target of $258.40.
Teleflex Stock Performance
Shares of TFX stock opened at $214.73 on Tuesday. The stock’s 50-day moving average is $199.10 and its two-hundred day moving average is $223.54. The firm has a market cap of $10.09 billion, a price-to-earnings ratio of 25.17, a PEG ratio of 2.28 and a beta of 1.04. Teleflex Incorporated has a 1 year low of $177.63 and a 1 year high of $276.43. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.51 and a current ratio of 3.58.
Teleflex Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 15th. Shareholders of record on Wednesday, November 15th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.63%. The ex-dividend date of this dividend is Tuesday, November 14th. Teleflex’s payout ratio is 15.94%.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
- Five stocks we like better than Teleflex
- What Are Dividend Champions? How to Invest in the Champions
- Safeguard your portfolio with these three bargain stocks
- How to Use the MarketBeat Stock Screener
- Membership clubs gain leverage for the consumer rebound
- Financial Services Stocks Investing
- Advanced Auto Parts may be worth more in pieces than the whole
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.